Biotech and Pharmaceuticals
U.S. plans to stop buying Covid shots for the public this fall. Here’s what that means
A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store in October. Antonio Perez | Tribune News Service | Getty Images The U.S. will stop buying Covid shots at reduced price for the entire country and shift vaccine distribution to the private market as soon as early fall, shifting the cost to U.S. […]
Read More
GOP attorneys general warn CVS, Walgreens against mailing abortion pill in their states
Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022. Robyn Beck | AFP | Getty Images Republican attorneys general in 20 states warned CVS and Walgreens this week against mailing […]
Read More
Roche flags 2023 earnings decline on slump in Covid merchandise
A perspective of the Roche towers, built by architects Herzog and de Meuron, the headquarters of the Swiss pharma large Roche, in Basel. Gabriel Monnet | Afp | Getty Photos Roche warned of a decline in 2023 earnings, as revenue growth from new medicines like haemophilia treatment method Hemlibra and several sclerosis drug Ocrevus would […]
Read More
Beware of tech shares — these hard cash-prosperous names are a better guess, analysts say
Ignore advancement shares like tech. Analysts are recommending that buyers go for companies with a lot of dollars. The market rallied in January — such as the tech-large Nasdaq Composite, which rose approximately 10.7% previous thirty day period for its most effective month-to-month overall performance given that July. But analysts say providers with pricing power […]
Read More
The Covid pandemic drives Pfizer’s 2022 revenue to a record $100 billion
Empty vials of Pfizer-BioNTech coronavirus disease (COVID-19) children’s vaccines are pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, U.S., May 19, 2022. Hannah Beier | Reuters The ongoing Covid-19 pandemic propelled pharmaceutical company Pfizer’s earnings to a record $100 billion last year, almost $57 billion of which was driven by its vaccine and antiviral pill Paxlovid, […]
Read More
The end of the Covid health emergency won’t slow FDA clearance of shots and treatments
Vials and a medical syringe seen displayed in front of the Food and Drug Administration (FDA) of the United States logo. FDA finds the COVID-19 vaccine. Pavlo Gonchar | LightRocket | Getty Images The Food and Drug Administration on Tuesday said its emergency authorizations of Covid vaccines, tests and treatments will not be impacted by […]
Read More
Pfizer expects 2023 sales to decline as much as 33% compared with record-breaking 2022
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday issued sales guidance of $67 billion to $71 billion for 2023, a decline from its record-breaking 2022 results. The pharmaceutical company booked […]
Read More
Google’s ex-CEO Eric Schmidt tapped for federal biotech commission that allows members to keep biotech investments
On Dec. 30, leaders of the House and Senate Armed Services committees announced the selection of former Google CEO Eric Schmidt and 11 others to serve on a new federal commission on biotechnology. Tasked with reviewing the biotech industry and suggesting investments that would benefit U.S. security, the National Security Commission on Emerging Biotechnology is […]
Read More
Obamacare enrollment to open this spring for people losing Medicaid after pandemic protections end
Millions of people in the U.S. are at risk of losing Medicaid this year when coverage protections put in place during the Covid-19 pandemic come to an end in April. To make it easier for these individuals to transition to other coverage, the Health and Human Services Department has announced a special enrollment period for […]
Read More
Observe: Biden touts most recent infrastructure project, changing a 150-calendar year-old prepare tunnel in Baltimore
U.S. President Joe Biden is in Baltimore on Monday to laud the hottest undertaking funded by his Bipartisan Infrastructure Regulation, highlighting the state’s ideas to switch a 150-12 months-outdated tunnel that operates Amtrak trains concerning Washington, D.C., and New York City. The present Baltimore and Potomac Tunnel opened through the Ulysses S. Grant administration and […]
Read More